Dysport® Pediatric Lower Limb Spasticity Follow-on Study
The purpose of this research study was to determine the long term safety and efficacy of repeated treatments with Dysport® used in the treatment of lower limb spasticity in children with dynamic equinus foot deformity due to cerebral palsy.
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
- 26 Juin 2024 - 1 mn de lecture
The purpose of this research study was to determine the long term safety and efficacy of repeated treatments with Dysport® used in the treatment of lower limb spasticity in children with dynamic equinus foot deformity due to cerebral palsy.
En rapport Clinical Trials
![Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
![Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
![Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
![Dysport® Adult Lower Limb Spasticity Follow-on Study Dysport® Adult Lower Limb Spasticity Follow-on Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
![Dysport® Pediatric Lower Limb Spasticity Study Dysport® Pediatric Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
![Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
![Dysport® Adult Lower Limb Spasticity Study Dysport® Adult Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
![Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
![Dysport in the Treatment of Glabellar Lines in Chinese Subjects Dysport in the Treatment of Glabellar Lines in Chinese Subjects](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture
Dysport in the Treatment of Glabellar Lines in Chinese Subjects
![Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 Juin 2024
1 mn de lecture